Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes Care 30:677-682, 2007
DOI: 10.2337/dc06-1834
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cnop, M.
Right arrow Articles by Kahn, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cnop, M.
Right arrow Articles by Kahn, S. E.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Pathophysiology/Complications
Original Article

Progressive Loss of ß-Cell Function Leads to Worsening Glucose Tolerance in First-Degree Relatives of Subjects With Type 2 Diabetes

Miriam Cnop, MD, PHD1, Josep Vidal, MD, PHD1, Rebecca L. Hull, PHD1, Kristina M. Utzschneider, MD1, Darcy B. Carr, MD2, Todd Schraw, PHD3, Philipp E. Scherer, PHD3, Edward J. Boyko, MD4, Wilfred Y. Fujimoto, MD1 and Steven E. Kahn, MB, CHB1

1 Division of Metabolism, Endocrinology, and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle, Washington
2 Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington
3 Departments of Cell Biology and Medicine, Diabetes Research and Training Center, Albert Einstein College of Medicine, New York, New York
4 Division of General Internal Medicine, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle, Washington

Address correspondence and reprint requests to Steven E. Kahn, MB, ChB, VA Puget Sound Health Care System (151), 1660 S. Columbian Way, Seattle, WA 98108. E-mail: skahn{at}u.washington.edu

OBJECTIVE—The relative roles of insulin resistance and ß-cell dysfunction in the pathogenesis of impaired glucose tolerance (IGT) and type 2 diabetes are debated. First-degree relatives of individuals with type 2 diabetes are at increased risk of developing hyperglycemia.

RESEARCH DESIGN AND METHODS—We evaluated the evolution of insulin sensitivity, ß-cell function, glucose effectiveness, and glucose tolerance over 7 years in 33 nondiabetic, first-degree relatives of type 2 diabetic individuals using frequently sampled tolbutamide-modified intravenous and oral glucose tolerance tests.

RESULTS—Subjects gained weight, and their waist circumference increased (P < 0.05). Insulin sensitivity, the acute insulin response to glucose, and glucose effectiveness did not change significantly. However, when we accounted for the modulating effect of insulin sensitivity on insulin release, ß-cell function determined as the disposition index decreased by 22% (P < 0.05). This decrease was associated with declines in intravenous and oral glucose tolerance (P < 0.05 and P < 0.001, respectively). Of the subjects with normal glucose tolerance at the first assessment, we compared those who progressed to IGT with those who did not. The disposition index was 50% lower in the progressors than in the nonprogressors at follow-up (P < 0.05).

CONCLUSIONS—The decline in glucose tolerance over time in first-degree relatives of type 2 diabetic individuals is strongly related to the loss of ß-cell function. Thus, early interventions to slow the decline in ß-cell function should be considered in high-risk individuals.

Abbreviations: AIRg, acute insulin response to glucose • AUCG, area under the curve for glucose • DI, disposition index • FSIGT, frequently sampled intravenous glucose tolerance test • GENNID, Genetics of Non-Insulin Dependent Diabetes Mellitus • GEZI, glucose effectiveness at zero insulin • IGT, impaired glucose tolerance • NGT, normal glucose tolerance • OGTT, oral glucose tolerance test


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Cell Sci.Home page
D. A. Cunha, P. Hekerman, L. Ladriere, A. Bazarra-Castro, F. Ortis, M. C. Wakeham, F. Moore, J. Rasschaert, A. K. Cardozo, E. Bellomo, et al.
Initiation and execution of lipotoxic ER stress in pancreatic {beta}-cells
J. Cell Sci., July 15, 2008; 121(14): 2308 - 2318.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
D. L. Eizirik, A. K. Cardozo, and M. Cnop
The Role for Endoplasmic Reticulum Stress in Diabetes Mellitus
Endocr. Rev., February 1, 2008; 29(1): 42 - 61.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Rasouli, H. J. Spencer, A. A. Rashidi, and S. C. Elbein
Impact of Family History of Diabetes and Ethnicity on -Cell Function in Obese, Glucose-Tolerant Individuals
J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4656 - 4663.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.